Showing results (1-10 of 515) with videos related to
Sort By:
Pageof 52
JCO Oncology Practice|May 19, 2020
Potential of Circulating Tumor DNA for the Management of Patients With LymphomaSarah Huet, Gilles SallesNature Reviews. Cancer|February 10, 2018
From genetics to the clinic: a translational perspective on follicular lymphomaSarah Huet, Pierre Sujobert, Gilles SallesAmerican Journal of Hematology|March 2, 2017
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximabSarah Huet, Edith Szafer-Glusman, Bruno Tesson, et al.International Journal of Molecular Sciences|April 21, 2018
What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid MalignanciesYann Guillermin, Jonathan Lopez, Kaddour Chabane, et al.British Journal of Haematology|June 22, 2021
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copiesLucile Bussot, Simon Chevalier, Justine Cristante, et al.Nature Immunology|August 15, 2018
Human germinal center transcriptional programs are de-synchronized in B cell lymphomaPierre Milpied, Iñaki Cervera-Marzal, Marie-Laure Mollichella, et al.Hematology. American Society of Hematology. Education Program|December 4, 2020
How do I sequence therapy for follicular lymphoma?Gilles SallesThe American Journal of Surgical Pathology|August 2, 2021
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3BCamille Laurent, José Adélaïde, Arnaud Guille, et al.Pageof 52